Business English Lite | Health care in Japan 日本の医療

2013/03/01

Health care in Japan 日本の医療

Japan is benefiting from a transformation in the way it approves, pays for and administers drugs. The goal is to spark innovation and slow rising age-related health costs.

For foreign drug companies, it’s the best market in the world right now. Sales growth for the top eight multinational drug firms in Japan in 2011 ranged from 12% to 31%, which are "emerging-market" growth rates. The firms are now sending some of their brightest researchers to Japan.

Deregulation has come in three areas. First, the government has speeded up its review of new drugs. The greatly expanded Pharmaceuticals and Medical Devices Agency (PMDA) has slashed review times since 2008 and increased the number of new drugs it has approved

Second, the pricing system is under review. Previously, the price of new drugs would be lowered every two years. This made it hard to cover the cost of innovation. Soon, the price of new medicines will be maintained through the life of the patent, which would make them more profitable.

Third, the authorities have said that 30% of the volume of drugs sold should be generics, a goal it has almost reached. This has hit smaller Japanese drug firms, but it helps others.

Key Vocabularies :

benefit [verb] 何かから良いものを受け取ること, transformation [noun] 大きな変化, approve [verb] 正式に認めること, spark [verb] 刺激する、引き起こす, innovation [noun] 新しいものまたは異なるもの、イノベーション,

Quiz

本文の内容や単語について問う問題です。問題は全部で5問あります。是非チャレンジしてみて下さい。

1. Because smaller, inefficient firms are being forced to close.

2. Because foreign researchers are working in Japan.

3. Because of the introduction of generics.

4. Because of deregulation.

1. Innovation will likely come to a stop because of deregulation of the industry.

2. Companies will be able to afford to bring in bright international researchers.

3. It will likely spark innovation.

4. It will provide a little more support than before for research.

1. very expensive drugs

2. drugs that are made abroad

3. drugs that are sold without a brand name

4. only brand-name drugs

1. increased considerably.

2. reduced significantly.

3. slowed down for reasons of safety.

4. cut completely.

1. They will encourage the small companies to come up with generics of their own.

2. The small firms will likely be forced to develop drugs on their own.

3. The small firms will have to produce only specialty drugs.

4. Generics will probably force some to go out of business.

月額1,000円〜最新のニュース記事で手軽に始めるビジネス英語学習

もっと沢山の記事を読んで学習をしたいなら、Business English Pro 、 1日10分ビジネス英語の受講がお薦めです！

Business English Pro と 1日10分ビジネス英語なら記事は週5日間、最新のニュースを使った学習記事が毎日配信されます。

ニュースソースは世界中の様々なニュース、メディアを元にスペシャリストにより作成されたオリジナルのニュース記事！
常に新しい記事で学習ができて、同時に最新の情報もインプットできます
「英語は勉強したいけど時間が…」という忙しいという方。ニュースを読む感覚で英語の学習ができます
スマートフォンから学習できるので、通勤時間や空き時間に手軽に学習できます
1日10分ビジネス英語なら月額980円で受講できます！ビジネス英語を手軽に学習したい方に最適です

さらに Business English Proなら

毎日レベル毎に難易度の異なる記事をそれぞれ配信。初級者から上級者までレベルに合わせた学習が可能です
過去に配信された記事のストックから、さかのぼってお好きなだけ学習が可能です
１週間の記事の復習をおこなう Weekly Reviewなど、通常の学習記事以外のコンテンツも充実しています
レベル修了テストで学習の成果を試すことができます。修了証の発行もおこなわれます

Business English Proについてもっと詳しく

1日10分ビジネス英語についてもっと詳しく

Health care in Japan 日本の医療

Quiz

1.
According to the article, why are international pharmaceutical giants in Japan experiencing emerging market rates of sales growth now?

2.
According to the article, how will the change in the pricing system affect innovation?

3.
Third, the authorities have said that 30% of the volume of drugs sold should be generics, a goal it has almost reached.

4.
The greatly expanded Pharmaceuticals and Medical Devices Agency (PMDA) has slashed review times since 2008 and increased the number of new drugs it has approved.
This means that the review times have been

5.
Based on the information in the article, what will the impact of generics have on small, older, Japanese pharmaceutical companies?

Health care in Japan 日本の医療

Quiz

1. According to the article, why are international pharmaceutical giants in Japan experiencing emerging market rates of sales growth now?

2. According to the article, how will the change in the pricing system affect innovation?

3. Third, the authorities have said that 30% of the volume of drugs sold should be generics, a goal it has almost reached.

4. The greatly expanded Pharmaceuticals and Medical Devices Agency (PMDA) has slashed review times since 2008 and increased the number of new drugs it has approved.This means that the review times have been

5. Based on the information in the article, what will the impact of generics have on small, older, Japanese pharmaceutical companies?

1.
According to the article, why are international pharmaceutical giants in Japan experiencing emerging market rates of sales growth now?

2.
According to the article, how will the change in the pricing system affect innovation?

3.
Third, the authorities have said that 30% of the volume of drugs sold should be generics, a goal it has almost reached.

4.
The greatly expanded Pharmaceuticals and Medical Devices Agency (PMDA) has slashed review times since 2008 and increased the number of new drugs it has approved.
This means that the review times have been

5.
Based on the information in the article, what will the impact of generics have on small, older, Japanese pharmaceutical companies?